Five things for pharma marketers to know: Wednesday, November 8, 2017

Share this content:


1. FDA commissioner Scott Gottlieb said the agency will make changes to its Risk Evaluation and Mitigation Strategy programs to stop pharma companies from using them to delay the approval of generic drugs. (Biocentury)

2. Ohioans rejected a proposed bill that would have forced the state to pay no more for prescription drugs than the Department of Veteran Affairs. (Fox)

3. Aetna CEO Mark Bertolini said he wants to create a better in-person experience for pharmacy customers. "We have conversations going on with Walmart and Walgreens and CVS, with all these players about creating an in-store concept that looks more like an Apple Store than it looks like a drug store," he said at a conference. (Axios)

4. A National Institutes of Health project will use Fitbits to gather information from one million people in the U.S. (Modern Healthcare)

5. Sales of Regeneron's eye-drug Eylea and eczema treatment Dupixent beat analyst estimates in the third quarter. (Reuters)

Share this content:
Scroll down to see the next article